Login / Signup

Oral nicotine product marketing expenditures in the USA from 2016 to 2023: trends over time by brand and targeted media outlets.

Jenny E OzgaJennifer Cornacchione RossMary HrywnaAkshika SharmaPamela M LingCassandra A Stanton
Published in: Tobacco control (2024)
Following FDA's regulatory authority over non-tobacco nicotine products, ad expenditures for Velo dropped to $0. Ongoing surveillance of ONP ad trends can inform FDA marketing authorisation decisions by revealing brand-specific marketing strategies that may be targeted toward populations at increased risk of tobacco use.
Keyphrases
  • smoking cessation
  • cancer therapy
  • health insurance
  • public health
  • transcription factor
  • genetic diversity